PPD, Inc.(PPD)

Sector:

Healthcare

Description:

PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.

Current Price

$47.28

RSI

56.82

Market Capitalization:

16.6B

Beta:

None

Analyst Target Price:

$ 47.22

Economiic Fair Price:


October 28, 2021
Q3
N/A
N/A
N/A
N/A
3.68 %
15.86
0

34.32 %
40.90 %
31.62 %
1008.24 %

$ 4.3B
6.87 %
$ 4B
7.52 %
$ 3.7B
24.92 %
$ 3B
12.00 %
$ 2.7B

$ 88M
-71.34 %
$ 307M
-0.08 %
$ 307.3M
21.00 %
$ 253.9M
-20.08 %
$ 317.7M

$ 187.5M
216.40 %
$ 59.3M
-59.58 %
$ 146.6M
790.34 %
$ 16.5M
-90.13 %
$ 166.9M

News

Press Releases

Notable Dates